Joint Formulary & PAD

Guideline Profile : Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs

Committee Recommendations (1)

14 Jan 26 - Not Set

The prescribing of drugs for ADHD in children and young people is supported by shared care agreements.

There are TWO shared care agreements for each drug. One for prescribers operating under the Locally Commissioned Service (LCS) and one for non-LCS.

Guideline Profile

Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
11